⌘K

Login Start Free

Home/Filings/4/0001209191-23-011255

4//SEC Filing

Suri Anish 4

Accession 0001209191-23-011255

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 5:01 PM ET

Size

5.3 KB

Accession

0001209191-23-011255

Insider Transaction Report

Form 4

Period: 2023-02-16

Cue Biopharma, Inc.CUE

Chief Scientific Officer

Transactions

Award
Stock Option (right to buy)
2023-02-16+125,500→ 125,500 total
Exercise: $3.21Exp: 2033-02-15→ Common Stock (125,500 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001739130

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 5:01 PM ET
Size: 5.3 KB

View on SEC.gov